Search Results - Douglas I. Lin

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas. by Jia Xu, Douglas I Lin

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  2. 2

    Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer by Helen Y. Hougen, Ryon P. Graf, Gerald Li, Julia C.F. Quintanilha, Douglas I. Lin, Jeffrey S. Ross, Sanoj Punnen, Brandon A. Mahal

    Published in European Urology Open Science (2023-09-01)
    Get full text
    Article


  3. 3

    An aggressive hematolymphoid neoplasm with homozygous <i>SMARCB1</i> loss shows response to EZH2 inhibition by Iman Sarami, Amy S. Duffield, Suchitra Sundaram, Douglas I. Lin, Christian Salib, Shafinaz Hussein, Siraj El Jamal, Nasrin Ghesani, Busra Cangut, Bruce E. Petersen

    Published in Haematologica (2025-06-01)
    Get full text
    Article


  4. 4

    Genomic landscape of 891 RET fusions detected across diverse solid tumor types by Vamsi Parimi, Khaled Tolba, Natalie Danziger, Zheng Kuang, Daokun Sun, Douglas I. Lin, Matthew C. Hiemenz, Alexa B. Schrock, Jeffrey S. Ross, Geoffrey R. Oxnard, Richard S. P. Huang

    Published in npj Precision Oncology (2023-01-01)
    Get full text
    Article


  5. 5

    Predicting EGFR mutational status from pathology images using a real-world dataset by James J. Pao, Mikayla Biggs, Daniel Duncan, Douglas I. Lin, Richard Davis, Richard S. P. Huang, Donna Ferguson, Tyler Janovitz, Matthew C. Hiemenz, Nathanial R. Eddy, Erik Lehnert, Moran N. Cabili, Garrett M. Frampton, Priti S. Hegde, Lee A. Albacker

    Published in Scientific Reports (2023-03-01)
    Get full text
    Article


  6. 6

    Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers by Douglas I. Lin, Richard S. P. Huang, Ioannis Ladas, Rachel B. Keller, Nimesh R. Patel, Sotirios Lakis, Brennan Decker, Tyler Janovitz, Douglas A. Mata, Jeffrey S. Ross, Jo-Anne Vergilio, Julia A. Elvin, Roy S. Herbst, Philip C. Mack, Jonathan K. Killian

    Published in Frontiers in Oncology (2024-02-01)
    Get full text
    Article


  7. 7

    Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab by Douglas I. Lin, Julia C. F. Quintanilha, Natalie Danziger, Lixin Lang, Diane Levitan, Cynthia Hayne, Matthew C. Hiemenz, David L. Smith, Lee A. Albacker, Jeffrey Leibowitz, Douglas A. Mata, Brennan Decker, Sotirios Lakis, Nimesh R. Patel, Ryon P. Graf, Julia A. Elvin, Jeffrey S. Ross, Varun Pattani, Richard S. P. Huang, Amy K. Wehn

    Published in npj Precision Oncology (2024-09-01)
    Get full text
    Article


  8. 8

    Primary Adult Retroperitoneal Sarcoma: A Comprehensive Genomic Profiling Study by Andrea Necchi, Giuseppe Basile, Filippo Pederzoli, Marco Bandini, Petros Grivas, Gennady Bratslavsky, Philippe E. Spiess, J. Keith Killian, Douglas I. Lin, Erik Williams, Shakti Ramkissoon, Eric A. Severson, Brian M. Alexander, Jeffrey Venstrom, Prasanth Reddy, Kimberley McGregor, Julia A. Elvin, Alexa B. Schrock, Dean V. Pavlick, Dexter X. Jin, Sally E. Trabucco, Natalie Danzinger, Jeffrey S. Ross

    Get full text
    Article


Search Tools: